%0 Journal Article
%T Clinical features, treatment, and outcome of juvenile dogs with meningoencephalitis of unknown etiology.
%A Galer J
%A Forward AK
%A Hughes J
%A Crawford AH
%A Behr S
%A Cherubini GB
%A Cornelis I
%A Royaux E
%J J Vet Intern Med
%V 0
%N 0
%D 2024 Jun 26
%M 38932495
%F 3.175
%R 10.1111/jvim.17126
%X <B>BACKGROUND: </B>The information relating to the outcome specifically for juvenile dogs with meningoencephalitis of unknown etiology (MUE) is lacking.<BR><B>OBJECTIVE: </B>To describe the clinical presentation, diagnostic findings, treatment, and outcome in a cohort of dogs with MUE <52 weeks old.<BR><B>METHODS: </B>Thirty-four client-owned dogs.<BR><B>METHODS: </B>Multicenter retrospective case series. Records from 5 referral centers were searched. Data was extracted from the medical records and referring veterinarians were contacted for survival data if this was not available from the record.<BR><B>RESULTS: </B>The mean age was 31 weeks; the youngest dog was 11 weeks and 3 dogs were <16 weeks old. Altered mentation (71%), ataxia (44%), seizures (29%), and circling (26%) were the most common presenting complaints. Neuroanatomical localization was to the forebrain (38%), multifocal (35%), brainstem (18%), and cerebellum (12%). Corticosteroid monotherapy (n = 15) and corticosteroid plus cytosine arabinoside (n = 15) were used in equal proportions. Outcome data was available for 26 dogs, 8 (31%) were alive at the time of data collection with a follow-up range of 135 to 2944 days. Death or euthanasia was related to MUE in 17/18 dogs that died during the study period. Kaplan-Meier survival analysis demonstrated a median survival time for all-cause death of 84 days.<BR><B>CONCLUSIONS: </B>The prognosis for MUE in this subset of dogs was considered poor.